| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 24/01/2019 | 14h08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 24/01/2019 | 14h06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 24/01/2019 | 14h01 | GlobeNewswire Inc. | Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage ... | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 24/01/2019 | 12h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 24/01/2019 | 12h06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 16/01/2019 | 23h32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 16/01/2019 | 23h30 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 15/01/2019 | 13h00 | GlobeNewswire Inc. | Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc. | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 05/01/2019 | 00h05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 04/01/2019 | 23h58 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 04/01/2019 | 18h08 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 26/12/2018 | 22h12 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 17/12/2018 | 12h15 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 17/12/2018 | 12h15 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 17/12/2018 | 12h10 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 14/12/2018 | 22h49 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 14/12/2018 | 22h47 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 14/12/2018 | 18h30 | GlobeNewswire Inc. | Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 10/12/2018 | 13h00 | GlobeNewswire Inc. | Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018 | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 06/12/2018 | 14h08 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 30/11/2018 | 14h02 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 21/11/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 20/11/2018 | 23h23 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 20/11/2018 | 22h11 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 16/11/2018 | 23h33 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 16/11/2018 | 22h16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 16/11/2018 | 22h15 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 31/10/2018 | 21h37 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 31/10/2018 | 21h36 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 31/10/2018 | 21h24 | GlobeNewswire Inc. | Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results | NASDAQ:APRI | Apricus Biosciences, Inc. |